Fasenra

Medicinal product

(Invented) name

Fasenra

Active substance (s)

Benralizumabas

Strength

30 mg

Pharmaceutical form

injekcinis tirpalas užpildytame švirkšte

Route (s) of administration

leisti po oda

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

R03DX10, Benralizumab

Marketing authorisation holder

AstraZeneca AB, Švedija

Date of authorisation

2018-01-08

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Solution for injection in pre-filled syringe	1 ml
Benralizumabas	30 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
98687	84791	1084791	užpildytas švirkštas	1 ml N1		Receptinis	EU/1/17/1252/001	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2018-01-08	Registruotas